文献速递腹部MR

根据2019年WHO分类的肝细胞癌变异亚型:以影像为重点的综述

Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
PubMed 文献 · AJR Am J Roentgenol · 2022-02-16

2019年WHO第5版消化系统肿瘤分类指出,高达35%的肝细胞癌(HCC)可按分子特征归为八种亚型之一:脂肪性肝炎型、透明细胞型、巨梁索块型、硬癌型、嫌色细胞型、纤维板层型、富中性粒细胞型和富淋巴细胞型。这些亚型因细胞和结构特征独特,可能不表现为动脉期高强化和廓清,给无创诊断带来挑战,部分具有非典型影像特征的亚型预后更差。本综述描述了与各亚型相关的MRI特征,并强调影像表现有助于提示亚型存在,但确诊仍需组织学分析。

要点

  • 八种HCC亚型可能不表现典型动脉期高强化和廓清,需警惕非典型影像。
  • 某些亚型具有独特MRI特征,有助于提示亚型诊断并与良性病变鉴别。
  • 影像提示亚型存在,但组织学分析仍是确诊依据。

核心结论

  • 熟悉2019年WHO分类的HCC亚型及其影像特征,可使放射科医生提示亚型存在,但确诊仍需组织学分析。

研究设计与样本

  • 综述,基于2019年WHO第5版消化系统肿瘤分类,描述各HCC亚型相关的MRI特征,并关注其病理和分子基础及临床实践相关性。

关键影像表现/征象

  • 脂肪性肝炎型、透明细胞型、巨梁索块型、硬癌型、嫌色细胞型、纤维板层型、富中性粒细胞型和富淋巴细胞型HCC可能不显示动脉期高强化和廓清表现。
  • 某些具有非典型影像特征的亚型预后较其他HCC更差。
  • 一系列影像特征有助于提示肝脏病变为某种HCC亚型。

诊断标准与关键数值

  • 2019年WHO第5版消化系统肿瘤分类估计高达35%的HCC可归为八种分子特征定义的亚型之一。

临床应用与阅片要点

  • 放射科医生熟悉这些亚型及其影像特征,可提示亚型存在,但组织学分析仍是确诊依据。
  • 影像表现有助于鉴别亚型与良性肝脏病变及非HCC恶性肿瘤。

局限性

  • 组织学分析仍是确立诊断所必需。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The 2019 5th edition of the WHO classification of digestive system tumors estimates that up to 35% of hepatocellular carcinomas (HCCs) can be classified as one of eight subtypes defined by molecular characteristics: steatohepatitic, clear cell, macrotrabecular-massive, scirrhous, chromophobe, fibrolamellar, neutrophil-rich, and lymphocyte-rich HCCs. Due to their distinct cellular and architectural characteristics, these subtypes may not display arterial phase hyperenhancement and washout appearance, which are the classic MRI features of HCC, creating challenges in noninvasively diagnosing such lesions as HCC. Moreover, certain subtypes with atypical imaging features have a worse prognosis than other HCCs. A range of distinguishing imaging features may help raise suspicion that a liver lesion represents one of these HCC subtypes. In this review, we describe the MRI features that have been reported in association with various HCC subtypes according to the 2019 WHO classification, with attention given to the current understanding of these subtypes' pathologic and molecular bases and relevance to clinical practice. Imaging findings that differentiate the subtypes from benign liver lesions and non-HCC malignancies are highlighted. Familiarity with these sub-types and their imaging features may allow the radiologist to suggest their presence, though histologic analysis remains needed to establish the diagnosis.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Loy, Low, Choi, et al. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review. AJR Am J Roentgenol. 2022. PMID: 35170359. doi:10.2214/AJR.21.26982

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。